Mariarosaria Calvello

Medicine & Life Sciences

1. Prostate Cancer, Hereditary, 7 100%
2. Prostatic Neoplasms 51%
3. Breast Neoplasms 49%
4. Hereditary Nonpolyposis Colorectal Neoplasms 41%
5. Virulence 36%
6. Genome-Wide Association Study 32%
7. Neoplasms 32%
8. Mutation 27%
9. Interstitial Lung Diseases 25%
10. Italy 23%
11. Patient Reported Outcome Measures 23%
12. sarilumab 20%
13. baricitinib 19%
14. Idiopathic Pulmonary Fibrosis 18%
15. Microsatellite Instability 16%
16. Confidence Intervals 16%
17. DNA Mismatch Repair 14%
18. Poly(ADP-ribose) Polymerase Inhibitors 13%
19. Germ-Line Mutation 13%
20. Myotonic Dystrophy 13%
21. Genetic Testing 13%
22. Coronavirus 13%
23. Decision Trees 13%
24. Thymoma 12%
25. Ovarian Epithelial Carcinoma 12%
26. Molecular Pathology 11%
27. Population 11%
28. Genes 11%
29. Rectal Neoplasms 10%
30. Noninvasive Ventilation 10%
31. human ERBB2 protein 9%
32. Colonic Neoplasms 9%
33. Adenosine Monophosphate 9%
34. Immunotherapy 9%
35. Neoplasm Genes 9%
36. Stomach Neoplasms 9%
37. Calibration 8%
38. Guidelines 8%
39. Colorectal Neoplasms 8%
40. Progesterone Receptors 8%
41. Genetic Predisposition to Disease 8%
42. Computational Biology 7%
43. Meta-Analysis 7%
44. Hospitalization 7%
45. Datasets 7%
46. BRCA2 Gene 7%
47. Computer Simulation 7%
48. Estrogen Receptors 7%
49. Obesity 7%
50. BRCA1 Gene 7%